Display Settings:

Format

Send to:

Choose Destination

    EMBO J. 2000 Jul 3;19(13):3263-71.

    Inhibition of human ether à go-go potassium channels by Ca(2+)/calmodulin.

    Schönherr R, Löber K, Heinemann SH.

    Arbeitsgruppe Molekulare und zelluläre Biophysik, am Klinikum der Friedrich-Schiller-Universität Jena, Drackendorfer Strabetae 1, D-07747 Jena, Germany.

    Intracellular Ca(2+) inhibits voltage-gated potassium channels of the ether à go-go (EAG) family. To identify the underlying molecular mechanism, we expressed the human version hEAG1 in XENOPUS: oocytes. The channels lost Ca(2+) sensitivity when measured in cell-free membrane patches. However, Ca(2+) sensitivity could be restored by application of recombinant calmodulin (CaM). In the presence of CaM, half inhibition of hEAG1 channels was obtained in 100 nM Ca(2+). Overlay assays using labelled CaM and glutathione S-transferase (GST) fusion fragments of hEAG1 demonstrated direct binding of CaM to a C-terminal domain (hEAG1 amino acids 673-770). Point mutations within this section revealed a novel CaM-binding domain putatively forming an amphipathic helix with both sides being important for binding. The binding of CaM to hEAG1 is, in contrast to Ca(2+)-activated potassium channels, Ca(2+) dependent, with an apparent K(D) of 480 nM. Co-expression experiments of wild-type and mutant channels revealed that the binding of one CaM molecule per channel complex is sufficient for channel inhibition.

    PMID: 10880439 [PubMed - indexed for MEDLINE]

    PMCID: PMC313935

    Supplemental Content

    Click here to read Click here to read

    Patient drug information

    • Potassium (Glu-K®, K+ 10®, K+ 8®, ...)

      Potassium is essential for the proper functioning of the heart, kidneys, muscles, nerves, and digestive system. Usually the food you eat supplies all of the potassium you need. However, certain diseases (e.g., kidney dis...